CardiologyTalk

Michael H. Davidson, MD, @mdavidsonmd @NewAmsPharma shares groundbreaking results from the ROSE2 Trial on Obacetrapib! Discover a remarkable LDL cholesterol reduction with Obacetrapib + Ezetimibe, paving the way for aggressive LDL-C goals. 🎯👏 [video] buff.ly/3L7O24V

🔬 Marc S. Sabatine, MD, from @BrighamWomens, pioneers MK0616, a Merck PCSK9 inhibitor. LDL cholesterol drops by 60.9% in hypercholesterolemia patients—a potential healthcare game-changer! [video]buff.ly/3sRbM6Z #CardioResearch #LDLCholesterol #Innovation 🌟

📢 Obacetrapib & Edizumab combo ROSE2 positive trial results in reduction of LDL cholesterol. Watch Michael Davidson @mdavidsonmd @NewAmsPharma discuss the results buff.ly/3L7O24V

Dr. Mason The study highlights the impact of mineral oil, corn oil, EPA, and DHA on phospholipid membrane oxidation rates. @BrighamWomens #Amarincorp #DeepakBhattMD #SamuelSherrattMD #PeterLibbyMD #ACC23 #WCCardio

Icosapent Ethyl from 🥼 Professor Philippe Steg's discussion on the REDUCE-IT trial. Exciting to explore the remarkable benefits for patients with recent ACS. @APHP #PhilippeStegMD #ACC23 #WCCardio Watch and Share the Video Here: cardiologytalk.com/v/793

@PrestonMasonPhD 🩺- How EPA can modulate platelet activation and thrombosis proteins in vascular endothelial cells during inflammation. @BrighamWomens #DeepakBhattMD #SamuelSherrattMD #PeterLibbyMD #ACC23 #WCCardio Watch and Share the Video Here: cardiologytalk.com/v/791

Atrial Fibrillation SOC: An Electrophysiologist Review [2022] @DJ_Lakkireddy @bariatricsurgkc #Electrophysiology #CardioTwitter medicusnetworks.net/3MNb6Fv

EV ICD Pivotal Study: Will This Eliminate Complications? @drpaulfriedman @MayoClinic @MayoClinicCV #CardioTwitter medicusnetworks.net/3CzlsEy

EV ICD Pivotal Study: Will This Eliminate Complications? @drpaulfriedman @MayoClinic @MayoClinicCV #CardioTwitter medicusnetworks.net/3S4SRwB

Phase 3 REDUCE-IT Trial Prakriti Gaba, MD @PrakritiGaba @DLBHATTMD @BrighamWomens @HarvardMed #REDUCEIT #CardioTwitter hubs.la/Q01bDZc30

Podcast - Non-RBC Blood Does Not Reduce Survival Following Surgery Ibrahim Sultan, MD @IbrahimSultanMD @HviUpmc @UPMC @UPMCPhysicianEd #CardioTwitter Link to Audio: hubs.la/Q01bDV0H0

Non-RBC Blood Does Not Reduce Survival Following Surgery Ibrahim Sultan, MD @IbrahimSultanMD @HviUpmc @UPMC @UPMCPhysicianEd #CardioTwitter hubs.la/Q01bDSZ90

Epi Scar-Homogenization With VS Without Epicardial Ablation Andrea Natale, MD @natale_md @tcainstitute #VT #ICM hubs.la/Q01b4vFV0

Podcast - Epi Scar-Homogenization With VS Without Epicardial Ablation Andrea Natale, MD @natale_md @tcainstitute #VT #ICM Link to Audio: hubs.la/Q01b4x9g0

Phase III ORION-9,10, and 11 Studies Scott Wright, MD @ScottWrightMD @MayoClinic #ORIONStudies hubs.la/Q01b4g9p0

Podcast - Phase III ORION-9,10, and 11 Studies Scott Wright, MD @ScottWrightMD @MayoClinic #ORIONStudies Link to Audio: hubs.la/Q01b48nH0

Phase 2 PACIFIC-AF Study Jonathan P. Piccini, MD @JonPicciniSr @DukeHeartCenter @DukeCardiology #PACIFICAF hubs.la/Q01b4rV00

Podcast - Phase 2 PACIFIC-AF Study Jonathan P. Piccini, MD @JonPicciniSr @DukeHeartCenter @DukeCardiology #PACIFICAF Link to Audio: hubs.la/Q01b4lnd0

Moving from “Candidacy” To “Benefit Derived” Drs. Lala and Mentz @dranulala @MountSinai @robmentz #JCF #wordsmatter hubs.la/Q01b40_l0

Podcast - Moving from “Candidacy” To “Benefit Derived” Drs. Lala and Mentz @dranulala @MountSinai @robmentz #JCF #wordsmatter Link to Audio: hubs.la/Q01b4lpF0